Predicting response to immune checkpoint inhibitors (ICI) in non-small-cell lung cancer (NSCLC) by combining spatial analysis of cells and RNA sequencing data from biopsies using deep learning (DL)
Thank you for your interest in Nucleai.
Click on the below button to download your requested publication.
